Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial (Q80336358)
Jump to navigation
Jump to search
scientific article published on 14 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial |
scientific article published on 14 May 2007 |
Statements
Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial (English)
Christoph Bode
John H Alexander
Marc Cohen
Deepak L Bhatt
Gilles Montalescot
Timothy Henry
Jean-Francois Tamby
Jan Saaiman
Stanislas Simek
Johannes De Swart
SEPIA-PCI Trial Investigators